Immune to Cancer: The CRI Blog
-
MUFG Pedal to the Medal: CRI Cycling Challenge
Fifty-five employees from the MUFG came together for the second annual “Pedal to the Medal: CRI Cycling Challenge,” a…
-
Speaking With Your Oncologist: The Importance of Building Trust and Open Dialogue
Brendan Connors and his oncologist, Michael Postow, MD, reunited for a special Cancer Immunotherapy Month webinar to…
-
Riding with a Purpose: Answer to Cancer Studio Cycling Event
At the second annual Answer to Cancer studio cycling event hosted by the CRI Associate Board, 36 dedicated…
-
CRI Celebrates a Future #Immune2Cancer on June 14 – Wear White Day
Supporters, scientists, patients, and advocates participated in CRI’s annual Wear White Day for a Future Immune to…
-
“Cancer Immunotherapy Insights from ASCO” Twitter Chat Recap #CIMchat
CRI hosted a Twitter Chat, moderated by STAT’s Sharon Begley, discussing takeaways from the ASCO19 conference last…
-
ASCO19 Recap: Caring for Every Patient, Learning from Every Patient
ASCO19 highlighted a number of immunotherapy developments, including those relating to long-term survival, introducing immunotherapy earlier, biomarkers,…
-
ASCO19 Day 5 Update: CAR T Cells for Pleural Cancers and More Melanoma News
The final day of ASCO19 covered CAR T cells for pleural cancers and long-term updates on several…
-
ASCO19 Day 4 Update: Kidney Cancer, Liver Cancer, Stomach Cancer, Esophageal Cancer, and Melanoma
The fourth day at ASCO19 highlighted immunotherapy strategies for patients with kidney cancer, liver cancer, stomach cancer,…
-
ASCO19 Day 3 Update: Immunotherapy for Brain Cancer, Ovarian Cancer, Lung Cancer, and Patients with HIV
The third day at ASCO19 highlighted immunotherapy strategies for patients with brain cancer, ovarian cancer, lung cancer,…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.